You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 234 No. 7, November 17, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

New drug introduction 1973-1974

P. de Haen

A review of the number of newly synthesized drugs introduced in the United States during the years 1973 and 1974 reveals that there has been an encouraging improvement in comparison with the previous two-year period. The number for 1971 to 1972 was 25, and for 1973 to 1974, thirty-seven. These drugs can be grouped into nine major therapeutic classifications. Some represent real advances in therapy; others enable the physician to vary his therapeutic regimen. In 1974, of all new and refill prescriptions, 68% were filled with 200 drugs. Of these, 126 contain one active ingredient, and 76 products contain more than one. The number of prescriptions written for each group is in close relationship to the number of drug products in each class.





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.